Z-2297-2019 Class II Terminated
FDA device recall Z-2297-2019 was initiated by Becton Dickinson & Company on Jun 12, 2019 and is designated Class II. Reason for recall: False elevation of carboxyhemoglobin (COHb) results have been reported when using venous blood gas samples collected with tubes analyzed with the IL GEM 4000 instrument. The recall status is terminated (terminated Jun 29, 2020). Affected quantity: 1,436,228,004 total.
Recall details
- Product Type
- Devices
- Report Date
- Aug 28, 2019
- Initiation Date
- Jun 12, 2019
- Termination Date
- Jun 29, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,436,228,004 total
Product description
BD Vacutainer Lithium HeparinN (LH) 56 USP Units Blood Collection Tubes, Catalog Number 366667
Reason for recall
False elevation of carboxyhemoglobin (COHb) results have been reported when using venous blood gas samples collected with tubes analyzed with the IL GEM 4000 instrument.
Distribution pattern
Worldwide Distribution, including US Nationwide
Code information
UDI: (01)30382903666677
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2297-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026